| Literature DB >> 33917402 |
Kuei-Hung Lai1,2,3, Zheng-Hao Huang4,5, Mohamed El-Shazly6,7, Bo-Rong Peng4,5, Wen-Chi Wei8, Jui-Hsin Su4,5.
Abstract
The marine sponge of the genus Geodia, Jaspis, Rhabdastrella, and Stelletta are characterized chemically by a variety of isomalabaricane triterpenes. This class of compounds drew spotlights in marine lead discovery due to their profound anti-proliferative properties. Further research on exploring its chemical diversity led to the identifications of two new isomalabaricane-type triterpenes rhabdastin H (1) and rhabdastin I (2). Their structures were unraveled using a series of spectroscopic approaches. These isolates were found to exhibit unique structural features with the only reported tetrahydrofuran functionality among all marine-derived isomalabaricanes. Both compounds 1 and 2 showed activities against K562 (IC50 11.7 and 9.8 μM) and Molt4 (IC50 16.5 and 11.0 μM) leukemic cells in MTT cell proliferative assay.Entities:
Keywords: anti-leukemia; isomalabaricane; tetrahydrofuran moiety
Mesh:
Substances:
Year: 2021 PMID: 33917402 PMCID: PMC8067365 DOI: 10.3390/md19040206
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1(A) Aquatic ecology of the sponge Rhabdastrella sp. and (B) the isolated isomalabaricane triterpenes.
1H, 13C, 1H–1H COSY, and HMBC NMR data of 1.
| Position | 1H–1H COSY | HMBC | ||
|---|---|---|---|---|
| 1 | 2.08 m; 1.46 m | 31.9 (CH2) | H-2 | C-3 |
| 2 | 2.66 m; 2.30 m | 33.7 (CH2) | C-3 | |
| 3 | 220.3 (C) | |||
| 4 | 46.8 (C) | |||
| 5 | 2.23 m | 45.7 (CH) | H-6 | |
| 6 | 1.45 m; 1.34 m | 20.0 (CH2) | H-5, H-7 | |
| 7 | 2.15 m; 1.35 m | 32.3 (CH2) | C-5, C-9 | |
| 8 | 42.2 (C) | |||
| 9 | 1.44 m | 52.9 (CH) | H-11 | |
| 10 | 35.0 (C) | |||
| 11 | 1.52 m; 1.30 m | 21.4 (CH2) | H-9, H-12 | C-9 |
| 12 | 1.85 m; 1.55 m | 25.4 (CH2) | H-11, H-13 | C-8, C-9, C-13 |
| 13 | 1.78 m | 59.8 (CH) | H-12 | |
| 14 | 86.2 (C) | |||
| 15 | 1.80 m | 38.6 (CH2) | H-16 | |
| 16 | 1.97 m; 1.58 m | 31.0 (CH2) | H-17 | |
| 17 | 3.76 ddd (14.0, 8.5, 4.5) | 79.8 (CH) | H-20 | |
| 18 | 1.17 s | 24.5 (CH3) | C-13, C-14, C-15 | |
| 19 | 0.79 s | 24.0 (CH3) | C-1, C-5, C-9, C-10 | |
| 20 | 2.70 m | 47.6 (CH) | H-17, H-21 | C-16, C-17 |
| 21 | 0.95 d (7.0) | 12.1 (CH3) | H-20 | C-17, C-20, C-22 |
| 22 | 207.4 (C) | |||
| 23 | 6.09 d (10.0) | 77.0 (CH) | H-24 | OAc |
| 24 | 5.11 d (10.0) | 116.9 (CH) | H-23 | |
| 25 | 142.6 (C) | |||
| 26 | 1.81 s | 26.0 (CH3) | C-24, C-25, C-27 | |
| 27 | 1.89 s | 19.0 (CH3) | C-24, C-25, C-26 | |
| 28 | 1.02 s | 19.3 (CH3) | C-3, C-4, C-5, C-29 | |
| 29 | 1.06 s | 29.3 (CH3) | C-3, C-4, C-5, C-28 | |
| 30 | 1.09 s | 31.8 (CH3) | C-7, C-8, C-9, C-13 | |
| OAc | 2.12 s | 20.9 (CH3)169.8 (C) |
500 MHz in CDCl3; 125 MHz in CDCl3; values (Hz) are given in parentheses; Numbers of the attached protons were deduced by DEPT experiments.
Figure 2Selected 1H-1H COSY and HMBC correlations of 1 and 2.
Figure 3Selected NOESY correlations for 1 and 2.
1H, 13C, 1H–1H COSY, and HMBC NMR data of 2.
| Position | 1H–1H COSY | HMBC | ||
|---|---|---|---|---|
| 1 | 1.48 m; 1.41 m | 33.9 (CH2) | H-2 | |
| 2 | 1.73 m; 1.61 m | 29.2 (CH2) | H-3 | |
| 3 | 3.24 dd (11.5,6.5) | 79.5 (CH) | ||
| 4 | 39.0 (C) | |||
| 5 | 1.54 m | 46.6 (CH) | H-6 | |
| 6 | 1.64 m; 1.38 m | 18.5 (CH2) | H-5, H-7 | |
| 7 | 2.04 m; 1.35 m | 32.9 (CH2) | ||
| 8 | 42.0 (C) | |||
| 9 | 1.42 m | 55.0 (CH) | H-11 | |
| 10 | 35.6 (C) | |||
| 11 | 1.49 m; 1.30 m | 21.2 (CH2) | H-9. H-12 | C-9 |
| 12 | 1.82 m; 1.54 m | 25.0 (CH2) | H-11, H-13 | |
| 13 | 1.78 m | 59.9 (CH) | H-12 | |
| 14 | 86.2 (C) | |||
| 15 | 1.80 m; 1.75 m | 38.8 (CH2) | H-16 | |
| 16 | 1.98 m; 1.60 m | 31.1 (CH2) | H-17 | |
| 17 | 3.75 ddd (13.5, 8.5, 4.5) | 79.5 (CH) | H-20 | |
| 18 | 1.16 s | 24.5 (CH3) | C-13, C-14, C-15 | |
| 19 | 0.95 s | 23.1 (CH3) | C-1, C-5, C-9, C-10 | |
| 20 | 2.69 ddd (13.5, 8.5, 1.5) | 47.5 (CH) | H-17, H-21 | C-16, C-17 |
| 21 | 0.94 d (6.0) | 12.1 (CH3) | H-20 | C-17, C-20, C-22 |
| 22 | 207.4 (C) | |||
| 23 | 6.10 d (10.0) | 78.7 (CH) | H-24 | C-22, C-24, OAc |
| 24 | 5.11 d (10.0) | 116.9 (CH) | H-23 | |
| 25 | 142.6 (C) | |||
| 26 | 1.81 s | 26.0 (CH3) | C-24, C-25, C-27 | |
| 27 | 1.89 s | 19.0 (CH3) | C-24, C-25, C-26 | |
| 28 | 0.98 s | 15.9 (CH3) | C-3, C-4, C-5, C-29 | |
| 29 | 0.78 s | 29.1 (CH3) | C-3, C-4, C-5, C-28 | |
| 30 | 1.04 s | 31.6 (CH3) | C-7, C-8, C-9, C-14 | |
| OAc | 2.10 s | 20.9 (CH3)169.8 (C) |
500 MHz in CDCl3; 125 MHz in CDCl3; values (Hz) are given in parentheses; Numbers of the attached protons were deduced by DEPT experiments.
Figure 4The plausible biosynthetic pathway of 2.
Anti-proliferative activities of compounds 1 and 2.
| Compounds | Cell Lines (IC50 μM) | |||
|---|---|---|---|---|
| DLD-1 | T-47D | Molt4 | K562 | |
|
| – | – | 16.54 | 11.71 |
|
| – | 17.48 | 11.03 | 9.81 |
| Doxorubicin | 0.42 | 0.18 | 0.02 | 0.28 |
IC50 > 20 μM; positive control.